← Leaderboards
Tyler Eugene Miller
Cleveland Clinic Lerner Com-Cwru
$823,129
Attributed
$823,129
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $211.5K · FY2014–25$250K$187.5K$125K$62.5K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$823,129 · 2
By mechanism
K08$634,392 · 1
F30$188,737 · 1
Top collaborators
No co-investigators on record.
Most similar at Cleveland Clinic Lerner Com-Cwru
Same institution · by research overlap
- Ranjan Dutta$3,783,325
- Jeongwu Lee$5,183,445
- Bruce D Trapp$26,095,443
- Tara Maria Desilva$4,694,945
- Shideng Bao$9,894,339
Others in their field
Top investigators on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Michael W Weiner · Northern California Institute Res &Educ$149,959,854
- David A Bennett · Rush University Medical Center$148,375,056
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$114,442,832
- Hongkui Zeng · Allen Institute$113,960,965
Research focus
BrainBrain NeoplasmsLaboratoriesTherapeutic TargetMalignant Neoplasm Of BrainDesignCellsGlioblastomaNeoplastic CellTumorProgramsMalignant NeoplasmsBiologyEpigenetic ProcessTargeted TreatmentAngiogenesisChemotherapyCell TypeCell SurvivalChemotherapeutic AgentClinicCell DeathBaseAzacitidine
Grant awards (8)
Targeting myeloid cells to increase efficacy of immunotherapy against brain tumors.$211,464
K08 · FY2025 · CA · contact PI
Targeting myeloid cells to increase efficacy of immunotherapy against brain tumors.$211,464
K08 · FY2024 · CA · contact PI
Targeting myeloid cells to increase efficacy of immunotherapy against brain tumors.$211,464
K08 · FY2023 · CA · contact PI
Targeting epigenetic regulation to disrupt glioma stem cell maintenance.$42,485
F30 · FY2017 · CA · contact PI
Targeting epigenetic regulation to disrupt glioma stem cell maintenance.$1,880
F30 · FY2017 · CA · contact PI
Targeting epigenetic regulation to disrupt glioma stem cell maintenance.$48,576
F30 · FY2016 · CA · contact PI
Targeting epigenetic regulation to disrupt glioma stem cell maintenance.$48,120
F30 · FY2015 · CA · contact PI
Targeting epigenetic regulation to disrupt glioma stem cell maintenance.$47,676
F30 · FY2014 · CA · contact PI